Boston Scientific BSX is slated to report fourth-quarter fiscal 2024 results on Feb. 5 before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. For fourth-quarter ...

Resbiotic Nutrition Inc. ("resbiotic" or "res"), a leading provider of physician-formulated and science-backed dietary supplements, has announced a strategic distribution agreement with Grupo Columbia ...

Boston Scientific Corporation develops ... such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making waves in the industry with its innovative product pipeline and strong market performance.

Piper Sandler analyst Matt O’Brien raised the firm’s price target on Boston Scientific (BSX) to $115 from $95 and keeps an Overweight rating on ...

TD Cowen raised the firm’s price target on Boston Scientific (BSX) to $115 from $110 and keeps a Buy rating on the shares. The firm expects ...

He's the best player still available and obviously would fill the right-handed hole Boston needs to sort out. While this is the case, what would he cost? This is the tricky question. It recently ...

This procedure may take place in a doctor’s office. What is the average cost of a spinal cord stimulator with Medicare? If you meet the criteria for spinal cord stimulation therapy, Original ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

WASHINGTON, Jan 31 (Reuters) - U.S. labor costs rose marginally in the fourth quarter, offering some comfort to Federal Reserve officials after progress lowering inflation stalled at the end of 2024.